2025/10/05 by Jin, Xu
#ATP synthesis #Alzheimer Disease #Antioxidants therapeutic use #Bioavailability #Cardiovascular Diseases #Chemotherapy-Induced Toxicity prevention and control #Coenzyme Q10 #Cognitive Neuroscience #Diabetes Mellitus Type II #Dietary Supplements #Dietetics and Clinical Nutrition #Diseases #Evidence-Based Medicine #Fatty Acids Omega-3 therapeutic use #Fatty Acids Omega-6 therapeutic use #Geriatrics #Human and Clinical Nutrition #Immunity #Immunology and Infectious Disease #Immunoprophylaxis and Therapy #International and Community Nutrition #KISEL-10 trial #Life Sciences #Medical Specialties #Medicine and Health Sciences #Minerals pharmacology #Mitochondria metabolism #Neoplasms #Nervous System Diseases #Neuroscience and Neurobiology #Nutrition #Nutritional Epidemiology #Nutritional Support #Nutritional and Metabolic Diseases #Oleic Acid metabolism #Other Nutrition #Parkinson Disease #Preventive Medicine #Primary Care #Psychiatry and Psychology #Q-SYMBIO trial #Reactive Oxygen Species metabolism #Skin Aging #Skin and Connective Tissue Diseases #Systems Neuroscience #VO₂max #Vitamins pharmacology #aging #angina pectoris #anti-aging medicine #antioxidant defense #bioenergetic regulation #cardiovascular protection #chronic fatigue syndrome (CFS) #clinical nutrition #collagen synthesis #coronary artery disease #dermal elasticity #electron transport chain #endothelial function #exercise performance #fatigue #functional supplementation #heart failure #inflammation #mitochondrial dysfunction #mitochondrial energy metabolism #neuroprotection #nutritional intervention #oxidative phosphorylation #oxidative stress #preventive health #proton motive force (PMF) #reactive oxygen species (ROS) #selenium synergy #statin-associated muscle symptoms (SAMS) #ubiquinol #ubiquinone
paper · doi:10.17605/osf.io/m68wk
This project explores Keyora Co-Q10 17 in 1 as an evidence-based multi-nutrient synergistic intervention designed to address energy-deficient, oxidative, and degenerative states underlying cardiovascular disease, neurodegenerative disorders, chronic fatigue, and age-related metabolic decline. Built upon the Three-Axis, Seven-Module Framework, the formulation integrates Coenzyme Q10 (Co-Q10), α-linolenic acid (ALA), linoleic acid (LA), oleic acid (OA), and a vitamin-mineral cofactor complex into a closed-loop biological system uniting mitochondrial energy generation, antioxidant defense, and structural-functional repair. Axis I – Mitochondrial Energy and Cellular Metabolism Modules I–II focus on ATP generation, mitochondrial electron transport efficiency, and fatigue recovery. High-dose Co-Q10 (250 mg/day) acts as the driving force for the energy chain, improving myocardial and neuronal energy output, enhancing endurance, and restoring metabolic resilience in energy-compromised states such as: - Chronic heart failure and cardiomyopathy (supported by Q-SYMBIO and KiSel-10 RCTs) - Parkinson’s disease and mitochondrial disorders - Exercise-induced fatigue and low-energy syndromes The formulation’s fatty-acid matrix (ALA, LA, OA) creates a lipid environment that promotes co-micellization and superior mitochondrial uptake, overcoming Co-Q10’s inherent bioavailability limitations. Axis II – Antioxidant and Endothelial Protection Modules III–IV establish a closed antioxidant network (Co-Q10 ↔ Vitamin E ↔ Vitamin C ↔ Glutathione) reinforced by selenium- and zinc-dependent enzymes. This tri-layered system: - Reduces lipid peroxidation and oxidative DNA damage - Protects vascular endothelium, improving microcirculation and nitric oxide bioavailability - Mitigates oxidative stress-driven hypertension, atherosclerosis, and diabetic microvascular complications Axis III – Systemic Intervention and Anti-Aging Continuum Modules V–VII extend the formulation’s application to: - Neurodegenerative diseases (AD, PD): supporting neuronal energy and anti-inflammatory signaling - Metabolic and drug-induced deficiency states (e.g., statin-induced Co-Q10 depletion, metformin-related B-vitamin loss) - Skin aging and barrier decline through mitochondrial repair and collagen stabilization The vitamin-mineral complex (C, E, B-group, selenium, zinc, magnesium) provides the enzymatic cofactor support necessary for maintaining redox balance, neurotransmitter synthesis, and tissue regeneration. Clinical Positioning and Population Relevance Keyora Co-Q10 17 in 1 is positioned as a systemic nutritional therapy platform rather than a single-target supplement. Applicable populations include: - Individuals with cardiovascular risk, heart failure, or hypertension - Patients with neurodegenerative or mitochondrial dysfunction - Those experiencing chronic fatigue, post-viral syndrome, or metabolic syndrome - Aging adults seeking anti-oxidative and anti-aging support By combining bioenergetic restoration, antioxidant network activation, and cellular resilience, the formulation embodies next-generation nutritional pharmacology—bridging clinical efficacy and preventive health.